Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GRAL NASDAQ:OPCH NASDAQ:PRVA NASDAQ:TALK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGRALGRAIL$71.80-0.3%$64.63$29.95▼$118.84$3.09B3.22573,068 shs367,119 shsOPCHOption Care Health$21.70+0.6%$21.06$18.01▼$36.80$3.39B0.652.36 million shs1.74 million shsPRVAPrivia Health Group$27.89+1.5%$23.82$18.77▼$27.96$3.46B0.831.15 million shs1.05 million shsTALKTalkspace$5.23$5.20$2.22▼$5.25$876.09M1.072.64 million shs1.94 million shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGRALGRAIL0.00%+4.18%+20.30%+49.88%+76.77%OPCHOption Care Health0.00%-1.51%+3.90%-25.44%-27.81%PRVAPrivia Health Group0.00%+0.48%+17.33%+19.47%+34.29%TALKTalkspace0.00%+0.58%+0.38%+0.97%+98.11%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGRALGRAIL$71.80-0.3%$64.63$29.95▼$118.84$3.09B3.22573,068 shs367,119 shsOPCHOption Care Health$21.70+0.6%$21.06$18.01▼$36.80$3.39B0.652.36 million shs1.74 million shsPRVAPrivia Health Group$27.89+1.5%$23.82$18.77▼$27.96$3.46B0.831.15 million shs1.05 million shsTALKTalkspace$5.23$5.20$2.22▼$5.25$876.09M1.072.64 million shs1.94 million shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGRALGRAIL0.00%+4.18%+20.30%+49.88%+76.77%OPCHOption Care Health0.00%-1.51%+3.90%-25.44%-27.81%PRVAPrivia Health Group0.00%+0.48%+17.33%+19.47%+34.29%TALKTalkspace0.00%+0.58%+0.38%+0.97%+98.11%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGRALGRAIL 2.30Hold$67.00-6.69% DownsideOPCHOption Care Health 2.71Moderate Buy$30.5440.73% UpsidePRVAPrivia Health Group 2.71Moderate Buy$31.1511.70% UpsideTALKTalkspace 2.00Hold$5.566.36% UpsideCurrent Analyst Ratings BreakdownLatest TALK, PRVA, OPCH, and GRAL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/7/2026PRVAPrivia Health Group Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell7/6/2026OPCHOption Care Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold7/2/2026PRVAPrivia Health Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C-) ➝ Hold (C)6/16/2026OPCHOption Care Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/8/2026OPCHOption Care Health The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy ➝ Neutral$22.006/8/2026OPCHOption Care Health The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$22.006/5/2026GRALGRAIL The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$60.006/5/2026GRALGRAIL The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$60.006/2/2026GRALGRAIL Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoveragePeer Perform5/26/2026PRVAPrivia Health Group BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$25.00 ➝ $24.005/12/2026TALKTalkspace Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Sell (D+)(Data available from 7/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGRALGRAIL$147.17M20.94N/AN/A$66.13 per share1.09OPCHOption Care Health$5.65B0.60$2.05 per share10.56$8.36 per share2.60PRVAPrivia Health Group$2.12B1.66$0.27 per share103.01$6.43 per share4.34TALKTalkspace$228.87M3.83$0.06 per share81.21$0.71 per share7.37Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGRALGRAIL-$408.35M-$10.37N/AN/AN/A-253.22%-16.42%-14.34%8/11/2026 (Estimated)OPCHOption Care Health$207.59M$1.2916.8211.791.203.64%18.17%7.16%7/29/2026 (Estimated)PRVAPrivia Health Group$22.92M$0.16174.3268.022.170.97%2.81%1.61%8/6/2026 (Estimated)TALKTalkspace$7.79M$0.01523.5223.77N/A0.49%1.03%0.88%8/4/2026 (Estimated)Latest TALK, PRVA, OPCH, and GRAL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026PRVAPrivia Health Group$0.08N/AN/AN/A$597.76 millionN/A8/4/2026Q2 2026TALKTalkspace$0.03N/AN/AN/A$67.89 millionN/A7/29/2026Q2 2026OPCHOption Care Health$0.42N/AN/AN/A$1.42 billionN/A5/11/2026Q1 2026TALKTalkspace$0.02-$0.04-$0.06-$0.04$63.32 million$61.68 million5/5/2026Q1 2026GRALGRAIL-$2.7629-$2.29+$0.4729-$2.29$39.16 million$40.79 million4/30/2026Q1 2026OPCHOption Care Health$0.37$0.40+$0.03$0.29$1.39 billion$1.35 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthGRALGRAILN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/APRVAPrivia Health GroupN/AN/AN/AN/AN/ATALKTalkspaceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGRALGRAILN/A11.7411.74OPCHOption Care Health0.851.641.07PRVAPrivia Health GroupN/A1.611.61TALKTalkspaceN/A4.844.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGRALGRAILN/AOPCHOption Care Health98.05%PRVAPrivia Health Group94.48%TALKTalkspace57.37%Insider OwnershipCompanyInsider OwnershipGRALGRAIL1.83%OPCHOption Care Health1.70%PRVAPrivia Health Group5.70%TALKTalkspace23.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGRALGRAIL1,36042.92 million42.13 millionOptionableOPCHOption Care Health8,266157.03 million154.36 millionOptionablePRVAPrivia Health Group1,226126.01 million118.83 millionOptionableTALKTalkspace500167.51 million128.15 millionOptionableTALK, PRVA, OPCH, and GRAL HeadlinesRecent News About These CompaniesTalkspace (NASDAQ:TALK) Reaches New 52-Week High - Time to Buy?July 13 at 10:59 AM | marketbeat.comTraditional AI chatbots were 'never developed' for therapy: Talkspace CEOJuly 8, 2026 | finance.yahoo.comSOPHiA GENETICS (NASDAQ:SOPH) versus Talkspace (NASDAQ:TALK) Head to Head ComparisonJuly 5, 2026 | americanbankingnews.comTalkspace Inc Ordinary Shares TALKJuly 4, 2026 | morningstar.comMApple’s Price Hike Backfires on Wall StreetJune 26, 2026 | cheddar.comCMeet the AI designed for mental health, not just conversationJune 25, 2026 | msn.comAI and mental health: Tool, trend, or the future of therapy?June 23, 2026 | msn.comInsider Selling: Talkspace (NASDAQ:TALK) Insider Sells $209,502.80 in StockJune 23, 2026 | insidertrades.comJohn Charles Reilly Sells 55,144 Shares of Talkspace (NASDAQ:TALK) StockJune 17, 2026 | insidertrades.comTalkspace Just Launched an AI Therapist—With 1 Major CatchJune 13, 2026 | inc.comWill AI replace therapists? What experts sayJune 10, 2026 | aol.comATalkspace Announces ‘Tee,’ the First Safe AI Agent Specifically Developed to Help Individuals Navigate Life’s Daily Mental Health ChallengesJune 9, 2026 | finance.yahoo.comTalkspace Announces ‘Tee,' the First Safe AI Agent Specifically Developed to Help Individuals Navigate Life's Daily Mental Health ChallengesJune 9, 2026 | businesswire.comTalkspace Stockholders Vote to Approve Acquisition by UHSMay 29, 2026 | globenewswire.comWhy billionaire George Soros is betting big on Talkspace stockMay 24, 2026 | msn.comTALKW Talkspace, Inc. WT EXP 062126May 21, 2026 | seekingalpha.comCourt case exposes privacy risks in digital therapy appsMay 13, 2026 | msn.comCourt records are raising questions about the privacy of digital therapy platformsMay 13, 2026 | msn.comThe Fitbit app becomes Google Health, Canvas suffers major data breach, Talkspace expands U.S. Navy partnershipMay 8, 2026 | vator.tvVTalkspace expands U.S. Navy mental health partnership to 13 basesMay 7, 2026 | mobihealthnews.comMTalkspace Equity Warrant Exp 22 June 2026May 6, 2026 | cnbc.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 20265 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026SMRs Spark a Chain Reaction for Nano NuclearBy Jeffrey Neal Johnson | July 2, 2026Fiserv’s Debit Network Talks Raise a Bigger Question for Visa and MastercardBy Jeffrey Neal Johnson | July 9, 2026TALK, PRVA, OPCH, and GRAL Company DescriptionsGRAIL NASDAQ:GRAL$71.80 -0.20 (-0.28%) Closing price 04:00 PM EasternExtended Trading$71.82 +0.02 (+0.02%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.Option Care Health NASDAQ:OPCH$21.70 +0.13 (+0.60%) Closing price 04:00 PM EasternExtended Trading$21.70 +0.00 (+0.02%) As of 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.Privia Health Group NASDAQ:PRVA$27.89 +0.40 (+1.46%) Closing price 04:00 PM EasternExtended Trading$27.86 -0.03 (-0.09%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.Talkspace NASDAQ:TALK$5.23 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$5.24 +0.01 (+0.15%) As of 06:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The SK Hynix IPO and 2027’s AI Memory Squeeze Why Welltower's Growth Story Might Outrun Its Rich Valuation Why Micron Is Doubling Down While the HBM Shortage Persists AMD's 5C Deal Positions It as a Direct NVIDIA Rival China's Helium Ban Could Reshape the AI Supply Chain The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Analysts See Major Upside for These 5 Stocks One Short- and One Long-Term ETF for Quantum Computing Bulls Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
